Concepedia

Publication | Open Access

Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis

34

Citations

22

References

2017

Year

Abstract

These data provide new evidence for targeting p53 as a strategy to treat liver disease.

References

YearCitations

Page 1